{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T14:38:37Z","timestamp":1759588717085},"reference-count":17,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1507\/endocrj.k10e-329","type":"journal-article","created":{"date-parts":[[2010,12,28]],"date-time":"2010-12-28T05:20:22Z","timestamp":1293513622000},"page":"143-148","source":"Crossref","is-referenced-by-count":10,"title":["A case of myxedema coma caused by isolated thyrotropin stimulating hormone deficiency and Hashimoto's thyroiditis"],"prefix":"10.1507","volume":"58","author":[{"given":"Keiji","family":"Iida","sequence":"first","affiliation":[{"name":"Division of Diabetes and Endocrinology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhisa","family":"Hino","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ohara","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Chihara","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Hyogo Prefectural Kakogawa Medical Center, Kakogawa, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Nickerson JF, Hill SR Jr, McNeil JH, Barker SB (1960) Fatal myxedema, with and without coma. <i>Ann Intern Med<\/i> 53: 475-493.","DOI":"10.7326\/0003-4819-53-3-475"},{"key":"2","unstructured":"2. Wall CR (2000) Myxedema coma: diagnosis and treatment. <i>Am Fam Physician <\/i>62: 2485-2490."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rodr&iacute;guez I, Fluiters E, P&eacute;rez-M&eacute;ndez LF, Luna R, P&aacute;ramo C, Garc&iacute;a-Mayor RV (2004) Factors associated with mortality of patients with myxoedema coma: prospective study in 11 cases treated in a single institution. <i>J Endocrinol<\/i> 180: 347-350.","DOI":"10.1677\/joe.0.1800347"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nicoloff JT, LoPresti JS (1993) Myxedema coma: a form of decompensated hypothyroidism. <i>Endocrinol Metab Clin North Am<\/i> 22: 279-290.","DOI":"10.1016\/S0889-8529(18)30166-X"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Fliers E, Wiersinga WM (2003) Myxedema coma. <i>Rev Endocr Metab Disord <\/i>4: 137-141.","DOI":"10.1023\/A:1022985902253"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wartofsky L (2006) Myxedema coma. <i>Endocrinol Metab Clin N Am <\/i>35: 687-698.","DOI":"10.1016\/j.ecl.2006.09.003"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Gupta MP, Kim S, Kang J, Sherman L, Kolodny HD, Hamby RI (1971) Isolated TSH deficiency presenting as myxedema heart disease. <i>JAMA<\/i> 217: 205-207.","DOI":"10.1001\/jama.1971.03190020063015"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Benvenga S, Squadrito S, Saporito F, Cimino A, Arrigo F, Trimarchi F (2000) Myxedema coma of both primary and secondary origin, with non-classic presentation and extremely elevated creatine kinase. <i>Horm Metab Res <\/i>32: 364-366.","DOI":"10.1055\/s-2007-978654"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.51.287"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.3.1054"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(89)90320-3"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Yamamoto M, Iguchi G, Takeno R, Okimura Y, Sano T, Takahashi M, Nishizawa H, Handayaningsih AE, Fukuoka H, Tobita M et al. (2011) Adult combined GH, prolactin and TSH deficiency associated with circulating PIT-1 antibody in humans. <i>J Clin Invest <\/i>121: 113-119.","DOI":"10.1172\/JCI44073"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-52-3-457"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650090617"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sugimoto T, Kaji H, Nakaoka D, Yamauchi M, Yano S, Sugishita T, Baylink DJ, Mohan S, Chihara K (2002) Effect of low-dose of recombinant human growth hormone on bone metabolism in elderly women with osteoporosis. <i>Eur J Endocrinol<\/i> 147: 339-348.","DOI":"10.1530\/eje.0.1470339"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-009-1121-9"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(03)00771-2"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/2\/58_K10E-329\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:55:02Z","timestamp":1618296902000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/endocrj\/58\/2\/58_K10E-329\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.k10e-329","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}